High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Clinical trial NCT07223385 · RECRUITING
Trial details
- NCT number
- NCT07223385
- Sponsor
- Cedars-Sinai Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.